Laying Out Regulatory Requirements & Strategies to Achieve Representative D&I in ADC Clinical Trials
- Explaining clinical trial processes and stressing the importance of regulatory requirements for clinical trial D&I
- Breaking down FDORA requirements and the D&I landscape in the US to understand impact on clinical trial recruitment and study
- Assessing differing strategies to achieve representative D&I across populations and locations